Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

November 2018; Volume 38,Issue 11

Reviews

  • You have access
    Molecular Basis of Drug Resistance and Insights for New Treatment Approaches in mCRPC
    SILVANA GIACINTI, GIULIA POTI, MICHELA ROBERTO, SERENA MACRINI, MARIA BASSANELLI, FRANCESCA DI PIETRO, ANNA MARIA ASCHELTER, ANNA CERIBELLI, ENZO MARIA RUGGERI and PAOLO MARCHETTI
    Anticancer Research November 2018, 38 (11) 6029-6039; DOI: https://doi.org/10.21873/anticanres.12953
  • You have access
    Technical Advances in Radiation Therapy for Brain Tumors
    CLAUDIA SCARINGI, LINDA AGOLLI and GIUSEPPE MINNITI
    Anticancer Research November 2018, 38 (11) 6041-6045; DOI: https://doi.org/10.21873/anticanres.12954
  • You have access
    Collision Tumors of the Gastrointestinal Tract: A Systematic Review of the Literature
    DIMITRIOS SCHIZAS, IOANNIS KATSAROS, ADAMANTIOS MICHALINOS, CHRISTOS DAMASKOS, NIKOLAOS GARMPIS, VASILEIA NTOMI, GEORGE AGROGIANNIS, SPYRIDON STERGIOPOULOS and ALEXANDRA K. TSAROUCHA
    Anticancer Research November 2018, 38 (11) 6047-6057; DOI: https://doi.org/10.21873/anticanres.12955

Experimental Studies

  • You have access
    Metastasis Suppressor NME1 Directly Activates Transcription of the ALDOC Gene in Melanoma Cells
    NIDHI V. PAMIDIMUKKALA, MARY KATHRYN LEONARD, DEVIN SNYDER, JOSEPH R. MCCORKLE and DAVID M. KAETZEL
    Anticancer Research November 2018, 38 (11) 6059-6068; DOI: https://doi.org/10.21873/anticanres.12956
  • You have access
    Transcriptomic Analysis of Histone Methyltransferase Setd7 Knockdown and Phenethyl Isothiocyanate in Human Prostate Cancer Cells
    CHAO WANG, DAVIT SARGSYAN, CHENGYUE ZHANG, RENYI WU, YUQING YANG and AH-NG KONG
    Anticancer Research November 2018, 38 (11) 6069-6083; DOI: https://doi.org/10.21873/anticanres.12957
  • You have access
    Cystathione β-Synthase Is Increased in Thyroid Malignancies
    ELBA A. TURBAT-HERRERA, MATTHEW J. KILPATRICK, JIE CHEN, ANDREW T. MERAM, JAMES COTELINGAM, GHALI GHALI, CHRISTOPHER G. KEVIL, DOMENICO COPPOLA and RODNEY E. SHACKELFORD
    Anticancer Research November 2018, 38 (11) 6085-6090; DOI: https://doi.org/10.21873/anticanres.12958
  • You have access
    7,8-Dihydroxy-3-arylcoumarin Induces Cell Death Through S-Phase Arrest in MDA-MB-231 Breast Cancer Cells
    MUSILIYU A. MUSA, VEERA L. D. BADISA, LEKAN M. LATINWO and ELIZABETH NTANTIE
    Anticancer Research November 2018, 38 (11) 6091-6098; DOI: https://doi.org/10.21873/anticanres.12959
  • You have access
    BUBR1 Insufficiency Is Correlated with eNOS Reduction Experimentally In Vitro and In Vivo, and in Gastric Cancer Tissue
    EISUKE KAWAKUBO, TAKUYA MATSUMOTO, KEIJI YOSHIYA, SHO YAMASHITA, TOMOKO JOGO, HIROSHI SAEKI, EIJI OKI, TADASHI FURUYAMA, YOSHINAO ODA and YOSHIHIKO MAEHARA
    Anticancer Research November 2018, 38 (11) 6099-6106; DOI: https://doi.org/10.21873/anticanres.12960
  • You have access
    CUB Domain-containing Protein 1 (CDCP1) Is Down-regulated by Active Hexose-correlated Compound in Human Pancreatic Cancer Cells
    KEISUKE KUHARA, KAZUHIRO TOKUDA, TAKAO KITAGAWA, BYRON BARON, MASAYUKI TOKUNAGA, KOJI HARADA, MASARU TERASAKI, OSAMU UEHARA, TOHRU OHTA, RIE TAKAI, JUN-ICHI HAMADA, MASANOBU KOBAYASHI, TSUYOSHI SHIMO, HIROKI NAGAYASU and YASUHIRO KURAMITSU
    Anticancer Research November 2018, 38 (11) 6107-6111; DOI: https://doi.org/10.21873/anticanres.12961
  • You have access
    Modified Nucleosides – Molecular Markers Suitable for Small-volume Cancer?
    PHILIPP OPITZ, OLF HERBARTH, ANNEROSE SEIDEL, ANDREAS BOEHM, MILOS FISCHER, CHRISTIAN MOZET, ANDREAS DIETZ and GUNNAR WICHMANN
    Anticancer Research November 2018, 38 (11) 6113-6119; DOI: https://doi.org/10.21873/anticanres.12962
  • You have access
    A Novel Combination Therapy for Human Oxaliplatin-resistant Colorectal Cancer Using Oxaliplatin and Coxsackievirus A11
    BEIBEI WANG, HISANOBU OGATA, YUTO TAKISHIMA, SHOHEI MIYAMOTO, HIROYUKI INOUE, MASAKI KURODA, KAZUNARI YAMADA, YASUKI HIJIKATA, MUTSUNORI MURAHASHI, HIROYUKI SHIMIZU, TOSHIHIKO OKAZAKI, YOICHI NAKANISHI and KENZABURO TANI
    Anticancer Research November 2018, 38 (11) 6121-6126; DOI: https://doi.org/10.21873/anticanres.12963
  • You have access
    IL-1β Induces Fascin Expression and Increases Cancer Invasion
    MIN KYEONG LEE, JI HYEON PARK, SEOL HWA GI and YOUNG SUN HWANG
    Anticancer Research November 2018, 38 (11) 6127-6132; DOI: https://doi.org/10.21873/anticanres.12964
  • You have access
    Colorectal Cancer Cell Line SW480 and SW620 Released Extravascular Vesicles: Focus on Hypoxia-induced Surface Proteome Changes
    ILVA NAKURTE, KASPARS JEKABSONS, REINIS REMBERGS, ELINA ZANDBERGA, ARTURS ABOLS, AIJA LINĒ and RUTA MUCENIECE
    Anticancer Research November 2018, 38 (11) 6133-6138; DOI: https://doi.org/10.21873/anticanres.12965
  • You have access
    PROX1 Is Associated with Cancer Progression and Prognosis in Gastric Cancer
    KOJI UETA, YASUNORI OTOWA, YOSHIHIRO KAKEJI and MASANORI HIRASHIMA
    Anticancer Research November 2018, 38 (11) 6139-6145; DOI: https://doi.org/10.21873/anticanres.12966
  • You have access
    TAK-733, a Selective MEK Inhibitor, Enhances Voreloxin-induced Apoptosis in Myeloid Leukemia Cells
    EWA JASEK-GAJDA, MARIUSZ GAJDA, MAŁGORZATA JASIŃSKA, JAN A. LITWIN and GRZEGORZ J. LIS
    Anticancer Research November 2018, 38 (11) 6147-6156; DOI: https://doi.org/10.21873/anticanres.12967
  • You have access
    Lymphangiogenesis and Lymph Node Metastasis in Oral Squamous Cell Carcinoma
    SATOMI ARIMOTO, TAKUMI HASEGAWA, DAISUKE TAKEDA, IZUMI SAITO, RIKA AMANO, MASAYA AKASHI and TAKAHIDE KOMORI
    Anticancer Research November 2018, 38 (11) 6157-6162; DOI: https://doi.org/10.21873/anticanres.12968
  • You have access
    Inhibiting xCT Improves 5-Fluorouracil Resistance of Gastric Cancer Induced by CD44 Variant 9 Expression
    SAWAKO MIYOSHI, HITOSHI TSUGAWA, JUNTARO MATSUZAKI, KENRO HIRATA, HIDEKI MORI, HIDEYUKI SAYA, TAKANORI KANAI and HIDEKAZU SUZUKI
    Anticancer Research November 2018, 38 (11) 6163-6170; DOI: https://doi.org/10.21873/anticanres.12969
  • You have access
    Casein Kinase 2 Inhibitor, CX-4945, as a Potential Targeted Anticancer Agent in Gastric Cancer
    HYUN MYONG KIM, INHYE JEONG, HYUN JEONG KIM, SUN KYOUNG KANG, WOO SUN KWON, TAE SOO KIM, KYU HYUN PARK, MINKYU JUNG, JOHN SOONG, SHU-CHUAN LIN, HYUN CHEOL CHUNG and SUN YOUNG RHA
    Anticancer Research November 2018, 38 (11) 6171-6180; DOI: https://doi.org/10.21873/anticanres.12970
  • You have access
    Benzoxazole-based Zn(II) and Cu(II) Complexes Overcome Multidrug-resistance in Cancer
    GABRIELLA SPENGLER, ANNAMÁRIA KINCSES, BÁLINT RÁCZ, BORISZ VARGA, GENKI WATANABE, RYOSUKE SAIJO, HIROSHI SEKIYA, EIJI TAMAI, JUN MAKI, JOSEPH MOLNÁR and MASAMI KAWASE
    Anticancer Research November 2018, 38 (11) 6181-6187; DOI: https://doi.org/10.21873/anticanres.12971
  • You have access
    Predicting Cytotoxicity of 2-Phenylindole Derivatives Against Breast Cancer Cells Using Index of Ideality of Correlation
    ANDREY A. TOROPOV and ALLA P. TOROPOVA
    Anticancer Research November 2018, 38 (11) 6189-6194; DOI: https://doi.org/10.21873/anticanres.12972
  • You have access
    Pharmacological Inhibition of Casein Kinase 2 Enhances the Effectiveness of PI3K Inhibition in Colon Cancer Cells
    CRYSTAL SEMAAN, KARLIE A. NEILSON, BENJAMIN BROWN and MARK P. MOLLOY
    Anticancer Research November 2018, 38 (11) 6195-6200; DOI: https://doi.org/10.21873/anticanres.12973
  • You have access
    Chronic Sulforaphane Application Does Not Induce Resistance in Renal Cell Carcinoma Cells
    JOCHEN RUTZ, EVA JUENGEL, STEPHANIE EULER, SEBASTIAN MAXEINER, SAIRA JUSTIN, FREDERIK ROOS, FELIX K.-H. CHUN and ROMAN A. BLAHETA
    Anticancer Research November 2018, 38 (11) 6201-6207; DOI: https://doi.org/10.21873/anticanres.12974
  • You have access
    Suppression of Taxanes Cytotoxicity by Citrus Flavonoid Hesperetin in PPC-1 Human Prostate Cancer Cells
    KATRIN SAK, HELEN LUST, MARJU KASE, MARIKA SAAR and JANA JAAL
    Anticancer Research November 2018, 38 (11) 6209-6215; DOI: https://doi.org/10.21873/anticanres.12975
  • You have access
    Oolong Tea Extract Induces DNA Damage and Cleavage and Inhibits Breast Cancer Cell Growth and Tumorigenesis
    HAIHONG SHI, JIN LIU, YIFAN TU, CARL E. FRETER and CHUNFA HUANG
    Anticancer Research November 2018, 38 (11) 6217-6223; DOI: https://doi.org/10.21873/anticanres.12976
  • You have access
    Dclk1 Inhibition Cancels 5-FU-induced Cell-cycle Arrest and Decreases Cell Survival in Colorectal Cancer
    YUKI SUEHIRO, YOSHIHIRO TAKEMOTO, ARATA NISHIMOTO, KOJI UENO, BUNGO SHIRASAWA, TOSHIKI TANAKA, NARUJI KUGIMIYA, ATSUSHI SUGA, EIJIRO HARADA and KIMIKAZU HAMANO
    Anticancer Research November 2018, 38 (11) 6225-6230; DOI: https://doi.org/10.21873/anticanres.12977
  • You have access
    Piperlongumine Induces Apoptosis in Colorectal Cancer HCT 116 Cells Independent of Bax, p21 and p53 Status
    FERNANDA DA SILVA MACHADO, FERNANDA MOSENA MUNARI, FERNANDO JOEL SCARIOT, SERGIO ECHEVERRIGARAY, CESAR AGUZZOLI, CLAUS TRÖGER PICH, MASSUO JORGE KATO, LYDIA YAMAGUCHI, SIDNEI MOURA, JOÃO ANTONIO PÊGAS HENRIQUES and MARIANA ROESCH-ELY
    Anticancer Research November 2018, 38 (11) 6231-6236; DOI: https://doi.org/10.21873/anticanres.12978
  • You have access
    An Experimental Model of Breast Cancer Cells: Informative Protocol for In Vitro Culture
    XINXIN DU, KRISTINA KLASCHIK, PETER MALLMANN, EVGENIA ISACHENKO, GOHAR RAHIMI, YUE ZHAO, CHRISTIANE BRUNS and VLADIMIR ISACHENKO
    Anticancer Research November 2018, 38 (11) 6237-6245; DOI: https://doi.org/10.21873/anticanres.12979
  • You have access
    Epigallocatechin-3-gallate Enhances Radiation Sensitivity in Colorectal Cancer Cells Through Nrf2 Activation and Autophagy
    TUMENJIN ENKHBAT, MASAAKI NISHI, KOZO YOSHIKAWA, HIGASHIJIMA JUN, TAKUYA TOKUNAGA, CHIE TAKASU, HIDEYA KASHIHARA, DAICHI ISHIKAWA, MASAHIDE TOMINAGA and MITSUO SHIMADA
    Anticancer Research November 2018, 38 (11) 6247-6252; DOI: https://doi.org/10.21873/anticanres.12980
  • You have access
    Coupling Dichloroacetate Treatment with Curcumin Significantly Enhances Anticancer Potential
    PING-CHUAN KAN, YU-JIA CHANG, CHIN-SUNG CHIEN, CHEN-YING SU and HSU-WEI FANG
    Anticancer Research November 2018, 38 (11) 6253-6261; DOI: https://doi.org/10.21873/anticanres.12981
  • You have access
    The Antitumor Effects of Metformin on Gastric Cancer In Vitro and on Peritoneal Metastasis
    NOBUFUMI SEKINO, MASAYUKI KANO, YASUNORI MATSUMOTO, HARUHITO SAKATA, KENTARO MURAKAMI, TAKESHI TOYOZUMI, RYOTA OTSUKA, MASAYA YOKOYAMA, TADASHI SHIRAISHI, KOICHIRO OKADA, TOSHIKI KAMATA, TAKAHIRO RYUZAKI and HISAHIRO MATSUBARA
    Anticancer Research November 2018, 38 (11) 6263-6269; DOI: https://doi.org/10.21873/anticanres.12982
  • You have access
    Blocking Interleukin-6 and Interleukin-8 Signaling Inhibits Cell Viability, Colony-forming Activity, and Cell Migration in Human Triple-negative Breast Cancer and Pancreatic Cancer Cells
    SHENGLING FU and JIAYUH LIN
    Anticancer Research November 2018, 38 (11) 6271-6279; DOI: https://doi.org/10.21873/anticanres.12983
  • You have access
    Phoyunnanin E Induces Apoptosis of Non-small Cell Lung Cancer Cells via p53 Activation and Down-regulation of Survivin
    PREEYAPORN PLAIMEE PHIBOONCHAIYANAN, NALINRAT PETPIROON, BOONCHOO SRITULARAK and PITHI CHANVORACHOTE
    Anticancer Research November 2018, 38 (11) 6281-6290; DOI: https://doi.org/10.21873/anticanres.12984
  • You have access
    Atypical Protein Kinase C λ/ι Expression Is Associated with Malignancy of Oral Squamous Cell Carcinoma
    JUNICHI BABA, MITOMU KIOI, KAZUNORI AKIMOTO, YOJI NAGASHIMA, MASATAKA TAGURI, YOSHIAKI INAYAMA, ICHIRO AOKI, SHIGEO OHNO, KENJI MITSUDO and IWAI TOHNAI
    Anticancer Research November 2018, 38 (11) 6291-6297; DOI: https://doi.org/10.21873/anticanres.12985
  • You have access
    Hypoxia Stimulates the Epithelial–to–Mesenchymal Transition in Lung Cancer Cells Through Accumulation of Nuclear β-Catenin
    KAO-HUI LIU, YI-TA TSAI, SZU-YING CHIN, WOAN-RUOH LEE, YEN-CHOU CHEN and SHING-CHUAN SHEN
    Anticancer Research November 2018, 38 (11) 6299-6308; DOI: https://doi.org/10.21873/anticanres.12986
  • You have access
    MicroRNA-107 Targets IKBKG and Sensitizes A549 Cells to Parthenolide
    SOKVISETH MOENG, HYUN AH SEO, CHO YEAN HWANG, GABRIEL A. CIPOLLA, DONG JIN LEE, HYO JEONG KUH and JONG KOOK PARK
    Anticancer Research November 2018, 38 (11) 6309-6316; DOI: https://doi.org/10.21873/anticanres.12987
  • You have access
    Deregulation of the SRC Family Tyrosine Kinases in Gastric Carcinogenesis in Non-human Primates
    JOANA DE FÁTIMA FERREIRA BORGES DA COSTA, CARLA DE CASTRO SANT' ANNA, JOSÉ AUGUSTO PEREIRA CARNEIRO MUNIZ, CARLOS ALBERTO MACHADO DA ROCHA, LETÍCIA MARTINS LAMARÃO, CAROLINE DE FÁTIMA AQUINO MOREIRA NUNES, PAULO PIMENTEL DE ASSUMPÇÃO and ROMMEL RODRIGUEZ BURBANO
    Anticancer Research November 2018, 38 (11) 6317-6320; DOI: https://doi.org/10.21873/anticanres.12988
  • You have access
    The Contribution of Interleukin-12 Genetic Variations to Taiwanese Lung Cancer
    MENG-FENG WU, YUN-CHI WANG, HSIN-TING LI, WEI-CHUN CHEN, CHENG-HSI LIAO, TZU-CHING SHIH, WEN-SHIN CHANG, CHIA-WEN TSAI, TE-CHUN HSIA and DA-TIAN BAU
    Anticancer Research November 2018, 38 (11) 6321-6327; DOI: https://doi.org/10.21873/anticanres.12989
  • You have access
    GLI1 and CTNNB1 Knockdown Activates NOTCH and mTOR Signalling in NB4 Myeloid Leukaemia Cells
    YUKI OKUHASHI, MAI ITOH and SHUJI TOHDA
    Anticancer Research November 2018, 38 (11) 6329-6332; DOI: https://doi.org/10.21873/anticanres.12990
  • You have access
    Expression Pattern of Cdkn2b and Its Regulators in Canine Mammary Tumors
    THAMIRYS ALINE SILVA FARO, DANILO DO ROSÁRIO PINHEIRO, DANIELLE QUEIROZ CALCAGNO, WASHINGTON LUIZ ASSUNÇÃO PEREIRA, LUCIEN ROBERTA VALENTE MIRANDA DE AGUIRRA, ROMMEL RODRIGUEZ BURBANO, MARIA LÚCIA HARADA and BÁRBARA DO NASCIMENTO BORGES
    Anticancer Research November 2018, 38 (11) 6333-6338; DOI: https://doi.org/10.21873/anticanres.12991
  • You have access
    Evodiamine Suppresses Survival, Proliferation, Migration and Epithelial–Mesenchymal Transition of Thyroid Carcinoma Cells
    SI HYOUNG KIM, JUN GOO KANG, CHUL SIK KIM, SUNG-HEE IHM, MOON GI CHOI and SEONG JIN LEE
    Anticancer Research November 2018, 38 (11) 6339-6352; DOI: https://doi.org/10.21873/anticanres.12992

Clinical Studies

  • You have access
    Combined Hepatic Resection and Radio-frequency Ablation for Patients with Colorectal Cancer Liver Metastasis: A Viable Option for Patients with a Large Number of Tumors
    TOSHIRO MASUDA, GEORGIOS ANTONIOS MARGONIS, NIKOLAOS ANDREATOS, JAEYUN WANG, SAMUEL WARNER, MUHAMMAD BILAL MIRZA, ANASTASIOS ANGELOU, CHRISTOS DAMASKOS, NIKOLAOS GARMPIS, KAZUNARI SASAKI, JIN HE, KATSUNORI IMAI, YO-ICHI YAMASHITA, CHRISTOPHER L. WOLFGANG, HIDEO BABA and MATTHEW J. WEISS
    Anticancer Research November 2018, 38 (11) 6353-6360; DOI: https://doi.org/10.21873/anticanres.12993
  • You have access
    Overexpression of the Pluripotent Stem Cell Marker Podocalyxin in Prostate Cancer
    ELISABETH I. HEATH, LANCE K. HEILBRUN, DARYN SMITH, WILLIAM M. SCHOPPERLE, YAWEN JU, SUSAN BOLTON, QURATULAIN AHMED and WAEL A. SAKR
    Anticancer Research November 2018, 38 (11) 6361-6366; DOI: https://doi.org/10.21873/anticanres.12994
  • You have access
    Improvement of Dysgeusia by Polaprezinc, a Zinc-L-carnosine, in Outpatients Receiving Cancer Chemotherapy
    HIRONORI FUJII, CHIEMI HIROSE, MASASHI ISHIHARA, HIROTOSHI IIHARA, HISASHI IMAI, YOSHIHIRO TANAKA, NOBUHISA MATSUHASHI, TAKAO TAKAHASHI, KAZUYA YAMAGUCHI, KAZUHIRO YOSHIDA and AKIO SUZUKI
    Anticancer Research November 2018, 38 (11) 6367-6373; DOI: https://doi.org/10.21873/anticanres.12995
  • You have access
    Underutilization of the CROSS Regimen Among US Radiation Oncologists: A National Survey of Practice Patterns
    DAVID A. ELLIOTT, SHUSHAN R. RANA, NIMA NABAVIZADEH, YIYI CHEN, AARON KUSANO, JOHN M. HOLLAND and TIMUR MITIN
    Anticancer Research November 2018, 38 (11) 6375-6379; DOI: https://doi.org/10.21873/anticanres.12996
  • You have access
    Radiofrequency Ablation vs. Cryoablation for Localized Hepatocellular Carcinoma: A Propensity-matched Population Study
    JIMMY XU, CHRISTOPHER NODA, ABIGAIL ERICKSON, MAHATI MOKKARALA, RESMI CHARALEL, RAJA RAMASWAMY, YU TAO and OLAGUOKE AKINWANDE
    Anticancer Research November 2018, 38 (11) 6381-6386; DOI: https://doi.org/10.21873/anticanres.12997
  • You have access
    Cancer Patients in the Emergency Department: A “Nightmare” that Might Become a Virtuous Clinical Pathway
    JACOPO MARIA LEGRAMANTE, STEFANIA PELLICORI, ANDREA MAGRINI, TIZIANA FRITTELLI, VINCENZO FORMICA and MARIO ROSELLI
    Anticancer Research November 2018, 38 (11) 6387-6391; DOI: https://doi.org/10.21873/anticanres.12998
  • You have access
    Long-term Survival of Stage IV Melanoma Patients Treated with BOLD Combination Chemotherapy and Intermediate-dose Subcutaneous Interferon-alpha
    KALLE MATTILA, PIRITA RAANTA, VALTTERI LAHTELA, SEPPO PYRHÖNEN, ILKKA KOSKIVUO and PIA VIHINEN
    Anticancer Research November 2018, 38 (11) 6393-6397; DOI: https://doi.org/10.21873/anticanres.12999
  • You have access
    Patients with hMLH1 or/and hMSH2-deficient Metastatic Colorectal Cancer Are Associated with Reduced Levels of Vascular Endothelial Growth Factor-1 Expression and Higher Response Rate to Irinotecan-based Regimen
    RIYAD BENDARDAF, FATEMEH SAHEB SHARIF-ASKARI, NARJES SAHEB SHARIF-ASKARI, KARI SYRJÄNEN and SEPPO PYRHÖNEN
    Anticancer Research November 2018, 38 (11) 6399-6404; DOI: https://doi.org/10.21873/anticanres.13000
  • You have access
    Whole-brain Radiation Therapy for Breast Cancer Patients with Dural Metastasis Without Concomitant Brain Metastasis and Leptomeningeal Metastasis
    MASAKUNI SAKAGUCHI, TOSHIYA MAEBAYASHI, TAKUYA AIZAWA and NAOYA ISHIBASHI
    Anticancer Research November 2018, 38 (11) 6405-6411; DOI: https://doi.org/10.21873/anticanres.13001
  • You have access
    Sunitinib Treatment Modification in First-Line Metastatic Renal Cell Carcinoma: Analysis of the STAR-TOR Registry
    MARTIN BOEGEMANN, MARCUS HUBBE, DESPINA THOMAIDOU, STUART BLACKBURN, NAWAL BENT-ENNAKHIL, ROBERT WOOD and DANIELLE BARGO
    Anticancer Research November 2018, 38 (11) 6413-6422; DOI: https://doi.org/10.21873/anticanres.13002
  • You have access
    Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in Israel
    MICHAL INBAR, YAIR HERISHANU, NETA GOLDSCHMIDT, OSNAT BAIREY, MONA YUKLEA, LEV SHVIDEL, RIVA FINEMAN, ARIEL AVIV, ROSA RUCHLEMER, ANDREI BRAESTER, DALLY NAJIB, ORY ROUVIO, ADIR SHAULOV, URI GREENBAUM, AARON POLLIACK and TAMAR TADMOR
    Anticancer Research November 2018, 38 (11) 6423-6429; DOI: https://doi.org/10.21873/anticanres.13003
  • You have access
    The Issue of Survival After Colorectal Liver Metastasis Surgery: Parenchyma Sparing vs. Radicality
    ANDRÁS PALKOVICS, ANDRÁS VERECZKEI, KÁROLY NAGY KALMÁR, ANDRÁS FINCSUR, ISVÁN KISS, BALÁZS NÉMETH and ANDRÁS PAPP
    Anticancer Research November 2018, 38 (11) 6431-6438; DOI: https://doi.org/10.21873/anticanres.13004
  • You have access
    Atypical Femoral Fractures (AFF) from Bone Remodeling Agents in Patients with Cancer
    MARIA KORDONI, GEORGIOS RIGAKOS, YOUNG HUN KIM, LOUKAS KAKLAMANIS, OURANIA NIKOLATOU-GALITIS, LINA HADJIYASSEMI, STEFANOS LABROPOULOS and EVANGELIA RAZIS
    Anticancer Research November 2018, 38 (11) 6439-6444; DOI: https://doi.org/10.21873/anticanres.13005
  • You have access
    Novel Extracorporeal Hemoperfusion System for Hepatic Arterial Infusion of Cisplatin
    SHINICHI SO, SHOHEI KOMATSU, ATSUSHI TAKEBE, MASAHIRO KIDO, MOTOFUMI TANAKA, HIROCHIKA TOYAMA, KIMIHIKO UENO and TAKUMI FUKUMOTO
    Anticancer Research November 2018, 38 (11) 6445-6452; DOI: https://doi.org/10.21873/anticanres.13006
  • You have access
    Salvage Carbon-ion Radiotherapy for Isolated Lymph Node Recurrence Following Curative Resection of Esophageal Cancer
    YUKA ISOZAKI, SHIGEO YASUDA, YASUNORI AKUTSU, HIDEAKI SHIMADA, SHINICHI OKAZUMI, YOSHIHIRO NABEYA, ISAMU HOSHINO, KENTARO MURAKAMI, DANIEL K. EBNER, HIROSHI TSUJI, TADASHI KAMADA, SHIGERU YAMADA and HISAHIRO MATSUBARA
    Anticancer Research November 2018, 38 (11) 6453-6458; DOI: https://doi.org/10.21873/anticanres.13007
  • You have access
    Geo-location of Oncological Diseases in the Extra-urban Areas of Naples and Creation of Territorial Biobanks: An Important Tool to Study Potential Connections Between Environmental Factors and Cancer
    MARGHERITA CERRONE, MONICA CANTILE, ORNELLA SACCO and GERARDO BOTTI
    Anticancer Research November 2018, 38 (11) 6459-6463; DOI: https://doi.org/10.21873/anticanres.13008
  • You have access
    Impact of Osteopenia in Liver Cirrhosis: Special Reference to Standard Bone Mineral Density with Age
    TAKEO TOSHIMA, TOMOHARU YOSHIZUMI, TORU IKEGAMI, NOBORU HARADA, SHINJI ITOH, YOHEI MANO, TAKASHI MOTOMURA, YUJI SOEJIMA and YOSHIHIKO MAEHARA
    Anticancer Research November 2018, 38 (11) 6465-6471; DOI: https://doi.org/10.21873/anticanres.13009
  • You have access
    Prognostic Significance of Conversion Surgery Following First- or Second-line Chemotherapy for Unresectable Gastric Cancer
    MINORU FUKUCHI, ERITO MOCHIKI, TORU ISHIGURO, YOUICHI KUMAGAI, KEIICHIRO ISHIBASHI and HIDEYUKI ISHIDA
    Anticancer Research November 2018, 38 (11) 6473-6478; DOI: https://doi.org/10.21873/anticanres.13010
  • You have access
    Plasma Catalase in Relation to Pain Following Midline Laparotomy: A Prospective Study of Patients with Benign Diseases and Patients with Cancer
    IINA SAIMANEN, JARI KÄRKKÄINEN, TUOMAS SELANDER, MARTIN PURDY, MERJA KOKKI, HANNU KOKKI and MATTI ESKELINEN
    Anticancer Research November 2018, 38 (11) 6479-6484; DOI: https://doi.org/10.21873/anticanres.13011
  • You have access
    Primary Tumor Size Predicts Distant Metastasis of Mucosal Malignant Melanoma in Head and Neck
    HIDENORI SUZUKI, GAKU TAKANO, NOBUHIRO HANAI, DAISUKE NISHIKAWA, YUSUKE KOIDE, SHINTARO BEPPU and YASUHISA HASEGAWA
    Anticancer Research November 2018, 38 (11) 6485-6490; DOI: https://doi.org/10.21873/anticanres.13012
  • You have access
    C-Reactive Protein-based Prognostic Measures Are Superior at Predicting Survival Compared with Peripheral Blood Cell Count-based Ones in Patients After Curative Resection for Pancreatic Cancer
    YUKI FUJIWARA, KOICHIRO HARUKI, HIROAKI SHIBA, RYOGA HAMURA, TAKASHI HORIUCHI, YOSHIHIRO SHIRAI, KENEI FURUKAWA, TAKESHI GOCHO and KATSUHIKO YANAGA
    Anticancer Research November 2018, 38 (11) 6491-6499; DOI: https://doi.org/10.21873/anticanres.13013
  • You have access
    Morphologic Response and Tumor Shrinkage as Early Predictive Markers in Unresectable Colorectal Liver Metastases
    TOSHIKI MASUISHI, HIROYA TANIGUCHI, TETSUYA ETO, AZUSA KOMORI, SEIICHIRO MITANI, HIROKO HASEGAWA, YUKIYA NARITA, MAKOTO ISHIHARA, TSUTOMU TANAKA, SHIGENORI KADOWAKI, TAKASHI URA, MASASHI ANDO, MASAHIRO TAJIKA, MOTOO NOMURA, YOZO SATO, HIDEYUKI MISHIMA and KEI MURO
    Anticancer Research November 2018, 38 (11) 6501-6506; DOI: https://doi.org/10.21873/anticanres.13014
  • You have access
    Comparison of Primary Tumor Size in Stage I and III Epithelial Ovarian Cancer
    EDGAR PETRU, CAROLA HUBER, EVA SAMPL and JOSEF HAAS
    Anticancer Research November 2018, 38 (11) 6507-6511; DOI: https://doi.org/10.21873/anticanres.13015
  • You have access
    Relationship Between Postoperative CRP and Prognosis in Thoracic Esophageal Squamous Cell Carcinoma
    KEITA KATSURAHARA, ATSUSHI SHIOZAKI, HITOSHI FUJIWARA, HIROTAKA KONISHI, MICHIHIRO KUDOU, KATSUTOSHI SHODA, TOMOHIRO ARITA, TOSHIYUKI KOSUGA, RYO MORIMURA, YASUTOSHI MURAYAMA, YOSHIAKI KURIU, HISASHI IKOMA, TAKESHI KUBOTA, MASAYOSHI NAKANISHI, KAZUMA OKAMOTO and EIGO OTSUJI
    Anticancer Research November 2018, 38 (11) 6513-6518; DOI: https://doi.org/10.21873/anticanres.13016
  • You have access
    The Potential Use of a Ketogenic Diet in Pancreatobiliary Cancer Patients After Pancreatectomy
    JU HYE OK, HOSUN LEE, HAE-YUN CHUNG, SUNG HWAN LEE, EUN JEONG CHOI, CHANG MOO KANG and SONG MI LEE
    Anticancer Research November 2018, 38 (11) 6519-6527; DOI: https://doi.org/10.21873/anticanres.13017
  • You have access
    Aggressive Cancer Behavior of Latent Gleason Pattern 5 in Prostatectomy Specimens
    TETSUYA FUJIMURA, HIROSHI FUKUHARA, YUTA YAMADA, SATORU TAGUCHI, TORU SUGIHARA, AYA NIIMI, MASAKI NAKAMURA, TOHRU NAKAGAWA, YASUHIKO IGAWA, YUKIO HOMMA and HARUKI KUME
    Anticancer Research November 2018, 38 (11) 6529-6535; DOI: https://doi.org/10.21873/anticanres.13018
  • You have access
    Feasibility of Combination Therapy with Nab-paclitaxel Plus Gemcitabine in Patients with Recurrent Pancreatic Cancer
    HIROMICHI KAWAIDA, HIROSHI KONO, HIDETAKE AMEMIYA, RYOU SAITOU, ATSUSHI YAMAMOTO, NAOHIRO HOSOMURA, MITSUAKI WATANABE, AYAKO KIMURA, SHINJI FURUYA, HIROKI SHIMIZU, HIDENORI AKAIKE, YOSHIHIKO KAWAGUCHI, MAKOTO SUDO, JUN ITAKURA, HIROSHI HAYAKAWA, HIROKO SHINDO, EI TAKAHASHI, SHINICHI TAKANO, MITSUHARU FUKASAWA, SHINTARO ICHIKAWA, HIDEKI FUJII and DAISUKE ICHIKAWA
    Anticancer Research November 2018, 38 (11) 6537-6542; DOI: https://doi.org/10.21873/anticanres.13019
  • You have access
    Negative Impact of Coexisting Interstitial Lung Disease on Clinical Outcomes in Small-cell Lung Cancer Patients
    KIMITAKA AKAIKE, KOICHI SARUWATARI, HIROKO OKABAYASHI, SHOHEI HAMADA, YASUMIKO JODAI, TAKAYUKI JODAI, SHINYA SAKATA, SHINJI IYAMA, RYO SATO, TOYOHISA IRIKI, YUSUKE TOMITA, SHO SAEKI, HIDENORI ICHIYASU and KAZUHIKO FUJII
    Anticancer Research November 2018, 38 (11) 6543-6550; DOI: https://doi.org/10.21873/anticanres.13020
  • You have access
    HSP27, ALDH6A1 and Prohibitin Act as a Trio-biomarker to Predict Survival in Late Metastatic Prostate Cancer
    SUNG YONG CHO, SUKI KANG, DONG SU KIM, HYUNG JIN NA, YE JIN KIM, YOUNG DEUK CHOI and NAM HOON CHO
    Anticancer Research November 2018, 38 (11) 6551-6560; DOI: https://doi.org/10.21873/anticanres.13021
  • You have access
    Case Report of a Patient with Breast Metastasis from Gastric Cancer Treated with Paclitaxel and Ramucirumab Plus Regional Hyperthermia
    JESSICA LUCCHETTI, VINCENZO FORMICA, GRETA GIULIANO, DEBORAH COLETTA, LETIZIA GARGANO, DANIELE MOROSETTI, PIERPAOLO SILERI, GIAMPIERO PALMIERI and MARIO ROSELLI
    Anticancer Research November 2018, 38 (11) 6561-6564; DOI: https://doi.org/10.21873/anticanres.13022
  • You have access
    Subcutaneous Trastuzumab Combined with Pertuzumab and Docetaxel as First-line Treatment of Advanced HER2-positive Breast Cancer
    DIMITRA STEFANOU, STEFANIA KOKKALI, ELLI-SOPHIA TRIPODAKI, MARIA DRIZOU, ELPIDA MAGOU, DIMOSTHENIS ZYLIS, MARIA PREVEZANOU, MATTHAIOS KAPIRIS, DESPOINA NASI, ANNA NTOKOU, MARY DEDE and ALEXANDROS ARDAVANIS
    Anticancer Research November 2018, 38 (11) 6565-6569; DOI: https://doi.org/10.21873/anticanres.13023
  • You have access
    Risk Factors for Regional and Systemic Metastases in Patients with Sentinel Lymph Node-negative Melanoma
    MICHAEL ERDMANN, DOMINIC SIGLER, UGUR USLU, JONAS GÖHL, ROBERT GRÜTZMANN, GEROLD SCHULER and VERA SCHELLERER
    Anticancer Research November 2018, 38 (11) 6571-6577; DOI: https://doi.org/10.21873/anticanres.13024
  • You have access
    Patterns of Recurrence After Salvage Radiotherapy Encompassing Pelvic Lymphatics in Men with High-risk Prostate Cancer
    MINJI KOH, YOUNG SEOK KIM, HANJONG AHN and CHOUNG-SOO KIM
    Anticancer Research November 2018, 38 (11) 6579-6584; DOI: https://doi.org/10.21873/anticanres.13025

BOOK REVIEWS

  • You have access
    Book Reviews
    Anticancer Research November 2018, 38 (11) 6585;
  • You have access
    The Adenosine Receptors
    Anticancer Research November 2018, 38 (11) 6585;
  • You have access
    Small Molecules in Oncology
    Anticancer Research November 2018, 38 (11) 6585;
  • You have access
    Single Cell Biomedicine
    Anticancer Research November 2018, 38 (11) 6585;
  • You have access
    The Human Virome. Methods and Protocols
    Anticancer Research November 2018, 38 (11) 6585;
  • You have access
    Programmed Necrosis. Methods and Protocols
    Anticancer Research November 2018, 38 (11) 6585-6586;
  • You have access
    Genetic Epidemiology. Methods and Protocols
    Anticancer Research November 2018, 38 (11) 6586;
  • You have access
    Stromal Immunology
    Anticancer Research November 2018, 38 (11) 6586;
  • You have access
    Gene Therapy in Reconstructive and Regenerative Surgery
    Anticancer Research November 2018, 38 (11) 6586;
  • You have access
    Molecular Applications in Cytology
    Anticancer Research November 2018, 38 (11) 6586;
  • You have access
    The Heterogeneity of Cancer Metabolism
    Anticancer Research November 2018, 38 (11) 6587;
  • You have access
    Nuclear-Cytoplasmic Transport
    Anticancer Research November 2018, 38 (11) 6587;
  • You have access
    Prebiotic Chemistry and Chemical Evolution of Nucleic Acids
    Anticancer Research November 2018, 38 (11) 6587;
  • You have access
    Cell Biology and Translational Medicine, Volume 1. Stem Cells in Regenerative Medicine: Advances and Challenges
    Anticancer Research November 2018, 38 (11) 6587;
  • You have access
    The Gut Microbiome in Health and Disease
    Anticancer Research November 2018, 38 (11) 6587;
  • You have access
    Behavioral Neurobiology of PTSD
    Anticancer Research November 2018, 38 (11) 6588;
  • You have access
    Statistical Methods in Medical Research
    Anticancer Research November 2018, 38 (11) 6588;
Back to top
PreviousNext

In this issue

Anticancer Research: 38 (11)
Anticancer Research
Vol. 38, Issue 11
November 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • BOOK REVIEWS
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire